The New York Times, June 26, 2023 (with Benjamin Mueller and Noah Weiland)
Efforts to develop the next generation of Covid vaccines are running up against bureaucratic hassles and regulatory uncertainty, scientists say, obstacles that could make it harder to curb the spread of the coronavirus and arm the United States against future pandemics.
The Biden administration, after months of delay, has now addressed at least a shortfall in funding, hurrying to issue the first major grants from a $5 billion program to expedite a new class of more potent and durable inoculations.
Continue reading “U.S. Vaccine Program Now Flush With Cash, but Short on Key Details”